The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis
Open accessAbstract
Objectives: To compare the judgments of clinicians on which domains of health in the short form questionnaire (SF-36) would be most important to patients with multiple sclerosis with the opinions of patients themselves; to compare assessment of physical disability in multiple sclerosis by a clinician using Kurtzke's expanded disability status scale and a non-clinically qualified assistant using the Office of Population Census and Surveys' (OPCS) disability scale with self assessment of disability and other domains of health related quality of life by patients using the SF-36 and the EuroQol questionnaire; and to compare the scores of patients for each domain of the SF-36 with control data matched for age and sex. Design: Cross sectional study. Setting: Clinical department of neurology, Edinburgh. Subjects: 42 consecutive patients with multiple sclerosis attending a neurology outpatient clinic for review or a neurology ward for rehabilitation. Main outcome measures: Scores on the SF-36; EuroQol; Kurtzke's expanded disability status scale; the OPCS disability scale. Results: Patients and clinicians disagreed on which domains of health status were most important (χ 2 =21, df=7, P=0.003). Patients' assessment of their physical disability using the physical functioning domain of the SF-36 was highly correlated with the clinicians' assessment ( r =-0.87, P<0.001) and the non-clinical assessment ( r =-0.90, P<0.001). However, none of the measures of physical disability correlated with overall health related quality of life measured with EuroQol. Quality of life correlated with vitality, general health, and mental health in the SF-36, each of which patients rated as more important than clinicians and for each of which patients scored lower than the controls. Conclusions: Patients with multiple sclerosis, and possibly those with other chronic diseases, are less concerned than their clinicians about physical disability in their illness. Clinical trials in multiple sclerosis should assess the effect of treatment on the other elements of health status that patients consider important, which are also affected by the disease process, are more closely related to overall health related quality of life, and may well be adversely affected by side effects of treatment. Key messages: Patients can accurately assess their own physical disability Physical disability may not always be the main determinant of overall health related quality of life Patients and clinicians differ in their assessments of the relative importance of different elements of health related quality of life The opinions of patients should be taken into account in the selection of outcome measures for clinical trials
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., & Westlake, L. (1992) · BMJ · doi:10.1136/bmj.305.6846.160 · Cited by 4,653
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390304 · Cited by 2,450
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Girard, M., Duquette, P., & Sibley, W. A. (1993) · Cited by 1,196
A health-related quality of life measure for multiple sclerosis
Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995) · Quality of Life Research · doi:10.1007/bf02260859 · Cited by 1,132
Who should measure quality of life, the doctor or the patient?
Slevin, M., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.20 · Cited by 904
Individual quality of life in patients undergoing hip replacement
O'Boyle, C. A., McGee, H., Hickey, A., O'Malley, K., & Joyce, C. R. B. (1992) · The Lancet · doi:10.1016/0140-6736(92)90673-q · Cited by 440
The prevalence of disability among adults
Martin, J., Meltzer, H., & Elliot, D. (1988) · Medical Entomology and Zoology · Cited by 358
Noseworthy, J. H., Ebers, G. C., Vandervoort, M. K., Farquhar, R. E., Yetisir, E., & Roberts, R. (1994) · Neurology · doi:10.1212/wnl.44.1.16 · Cited by 341
Quality of Life Following Spinal Cord Injury: Knowledge and Attitudes of Emergency Care Providers
Gerhart, K. A., Koziol-McLain, J., Lowenstein, S. R., & Whiteneck, G. G. (1994) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(94)70318-3 · Cited by 210
What do I want from health research and researchers when I am a patient?
Chalmers, I. (1995) · BMJ · doi:10.1136/bmj.310.6990.1315 · Cited by 202
Side effect profile of interferon beta-lb in MS: Results of an open label trial
Neilley, L. K., Goodin, D. S., Goodkin, D. E., & Hauser, S. L. (1996) · Neurology · doi:10.1212/wnl.46.2.552 · Cited by 171
Amato, M. P., Fratiglioni, L., Groppi, C., Siracusa, G., & Amaducci, L. A. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310052017 · Cited by 162
The rights of patients in research
Goodare, H., & Smith, R. W. (1995) · BMJ · doi:10.1136/bmj.310.6990.1277 · Cited by 125
Interpreting self reported limiting long term illness
Cohen, G., Forbes, J., & Garraway, M. (1995) · BMJ · doi:10.1136/bmj.311.7007.722 · Cited by 102
Measuring Patient-Centered Outcomes in Neurologic Disease: Extending the Q-TWiST Method
Schwartz, C. E., Cole, B. F., & Gelber, R. D. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540320026010 · Cited by 42
Hutchinson, J., & Hutchinson, M. (1995) · Journal of Neurology · doi:10.1007/bf00866915 · Cited by 18
Cited by
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Self-citationBaker, P. N., van der Meulen, J. H., Lewsey, J., & Gregg, P. J. (2007) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.89b7.19091 · Cited by 975
Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12)
Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003) · Neurology · doi:10.1212/wnl.60.1.31 · Cited by 821
Valderas, J. M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C. E., Halyard, M. Y., Revicki, D. A., Symonds, T., Parada, A., & Alonso, J. (2008) · Quality of Life Research · doi:10.1007/s11136-007-9295-0 · Cited by 775
Meyer-Moock, S., Feng, Y.-S., Maeurer, M., Dippel, F.-W., & Kohlmann, T. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-58 · Cited by 639
Metadata
- Authors
- Rothwell, P. M., McDowell, Z., Wong, C. K., & Dorman, P. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1997-05-31
- Volume
- 314
- Issue
- 7094
- Pages
- 1580
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2034417379
- Cited by
- 548
- References
- 20
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.